NEW YORK, May 2 – Pyrosequencing of Uppsala, Sweden said Wednesday its first quarter revenues jumped six-fold to $1.9 million, compared with $300,000 in the year-ago quarter.

The SNP company linked revenue increases to 17 new sales of their PSQ 96 System during the quarter, compared to five instruments in the same quarter in 2000. Additionally, Pyrosequencing reported a rise in an installed base of 80 systems for applied genetic analysis worldwide.

The company’s expenses rose to $5.1 million from $2.7 million for the first quarter of 2000.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

A research duo estimates in PLOS One the number of papers that have used misidentified cell lines.

UK's National Institute for Health and Care Excellence approves GlaxoSmithKline's SCID gene therapy despite cost.

Science reports that Brazilian researchers are petitioning for the reversal of budget cuts.

In PLOS this week: gene flow patterns in common ash, guidelines for using morpholinos in zebrafish, and more.